Last reviewed · How we verify
NCT05925426
Defining The Quality Of Intraoperatively Salvaged Blood For Deformity Surgery
trial in Spinal Deformity in 103 participants. Completed in 30 September 2023.
30 June 2023
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 103 |
| Start date | 1 July 2022 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across United States |
Conditions studied
- Spinal Deformity — all drugs for Spinal Deformity →
Sponsor
NYU Langone Health — full company profile →
Who can join
Eligibility, any sex, with Spinal Deformity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The actual quality of Red Blood Cells (RBCs) salvaged during spinal deformity surgery has never been rigorously evaluated. To characterize the usefulness of intraoperatively salvaged RBCs in spinal deformity surgery. The study team hopes to answer the following questions: 1) What is the quality of RBCs salvaged during spine surgery? 2) Does intraoperatively transfused RBC salvage impact clinical outcomes?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05925426
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spinal Deformity
Currently open trials in the same condition.
- NCT06603831 — Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology · NA · recruiting
- NCT06020417 — Pedicle Screw Malposition in Spine Arthrodesis Surgeries With O-ARM-guided Navigation · NA · recruiting
- NCT05648474 — Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure · recruiting
- NCT05146193 — AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations · recruiting
- NCT05108948 — Research of Factors Determining the Improvement of Quality of Life at One Year of Adult Patients Treated for Spinal Defo · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05925426 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 11 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05925426.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing